system
raa
play
import
role
pathophysiolog
heart
diseas
heart
failur
tradit
concept
raa
follow
cardiac
diseas
well
treatment
cardiac
diseas
diuret
decreas
perfus
kidney
activ
releas
renin
convert
angiotensinogen
acid
peptid
angiotensin
subsequ
enzym
ace
cleav
amino
acid
form
octapeptid
angiotensin
ii
angiotensin
ii
act
primarili
angiotensin
receptor
type
caus
potent
vasoconstrict
sodium
water
conserv
aldosteron
releas
myocardi
thu
tradit
view
raa
linear
maladapt
patholog
system
overact
heart
failur
often
suppress
use
ace
inhibitor
acei
aldosteron
antagonist
understand
chang
discoveri
homologu
ace
call
enzym
like
ace
zinc
metalloproteinas
catalyt
site
capabl
bind
variou
angiotensin
peptid
ap
howev
remov
singl
amino
acid
catalyt
exampl
act
produc
acid
peptid
call
angiotensin
acid
peptid
call
angiotensin
despit
differ
amino
acid
biolog
effect
opposit
associ
specif
vasodilatori
natriuret
diuret
antifibrot
benefici
ap
mediat
major
effect
bind
angiotensin
receptor
type
endogen
orphan
ma
receptor
masr
oppos
bind
system
provid
endogen
counterbal
ace
expand
view
raa
involv
mani
differ
ap
structur
differ
amino
acid
thu
raa
consider
complex
tradit
view
discoveri
uncov
broad
new
set
molecul
explor
understand
potenti
modifi
subject
heart
diseas
littl
known
system
relat
ap
veterinari
speci
best
knowledg
studi
dog
natur
occur
heart
diseas
lack
sought
detect
describ
locat
immunoreact
kidney
left
ventricular
lv
myocardium
quantifi
activ
plasma
kidney
lv
myocardi
determin
equilibrium
concentr
differ
circul
ap
determin
effect
recombin
human
rel
amount
benefici
versu
maladapt
ap
hypothes
evid
could
found
tissu
plasma
dog
equilibrium
concentr
raa
ap
would
differ
dog
heart
diseas
versu
healthi
dog
recombin
human
alter
rel
concentr
ap
cohort
dog
die
euthan
cardiac
diseas
dog
die
noncardiac
reason
univers
pennsylvania
recruit
section
left
kidney
includ
cortic
medullari
tissu
full
thick
lv
myocardi
sampl
later
wall
ventricl
apic
paracon
coronari
arteri
obtain
within
minut
death
kidney
myocardi
sampl
fix
neutral
buffer
formalin
hour
follow
section
rabbit
polyclon
primari
antibodi
aviva
system
biolog
san
diego
california
use
dilut
incub
section
minut
room
temperatur
rt
polymer
ihc
detect
system
consist
horseradish
peroxidas
conjug
igg
appli
minut
rt
final
slide
counterstain
hematoxylin
scan
leica
aperio
versa
slide
scanner
leica
biosystem
buffalo
grove
illinoi
imag
acquir
imagescop
leica
biosystem
buffalo
grove
illinoi
addit
detail
regard
ihc
method
found
support
inform
cohort
dog
year
age
activ
previou
congest
heart
failur
chf
caus
degen
mitral
valv
diseas
dmvd
prospect
recruit
criteria
dmvd
includ
left
apic
systol
murmur
echocardiograph
evid
thicken
prolaps
mitral
valv
leaflet
mitral
regurgit
echocardiograph
examin
philip
healthcar
andov
massachusett
record
left
ventricular
intern
dimens
end
diastol
lviddn
lvidsn
right
short
axi
view
normal
bodi
weight
use
previous
report
left
root
ratio
la
ao
calcul
use
measur
right
short
echocardiograph
valu
averag
valu
measur
beat
healthi
dog
primarili
own
staff
employe
veterinari
hospit
recruit
control
group
includ
dog
without
heart
murmur
clinic
sign
suggest
heart
diseas
control
dog
weigh
kg
echocardiogram
perform
exclud
potenti
occult
dilat
cardiomyopathi
dcm
venipunctur
perform
lithium
heparin
plasma
sampl
obtain
sampl
store
batch
analysi
activ
heparin
plasma
measur
use
fluorometr
assay
kit
biovis
inc
milpita
california
activ
result
report
milliunit
per
mg
protein
mumg
assay
lower
detect
limit
mu
addit
detail
regard
perform
valid
assay
describ
support
inform
cohort
dog
die
euthan
consequ
cardiac
diseas
dog
die
noncardiac
diseas
recruit
obtain
kidney
lv
myocardi
sampl
previous
describ
kidney
lv
myocardium
lysat
prepar
homogen
approxim
tissu
section
lysi
buffer
biovis
inc
use
dispos
tissu
homogen
fisher
thermo
scientif
waltham
massachusett
lysat
kept
ice
minut
follow
gentl
vortex
follow
anoth
minut
ice
tissu
lysat
centrifug
minut
pellet
discard
activ
tissu
lysat
measur
use
fluorometr
assay
kit
use
assay
plasma
activ
protein
concentr
plasma
tissu
lysat
measur
use
bicinchonin
acid
method
bovin
serum
albumin
protein
standard
biovis
inc
cohort
dog
year
age
dmvd
dcm
either
preclin
ie
asymptomat
chf
recruit
criteria
diagnosi
dmvd
dog
recruit
studi
plasma
activ
assay
criteria
diagnosi
dcm
presenc
systol
dysfunct
lv
eccentr
hypertrophi
echocardiographi
defin
lvidsn
lviddn
normal
refer
rang
absenc
identifi
cardiac
caus
previous
report
clinic
stage
system
dog
modifi
use
dog
specif
dog
segreg
preclin
asymptomat
heart
diseas
stage
b
current
histor
sign
chf
stage
c
sign
chf
refractori
standard
po
treatment
furosemid
acei
posit
inotrop
spironolacton
therefor
need
addit
diuret
hydrochlorothiazid
torsemid
stage
classif
dog
stage
b
occur
depend
absenc
stage
presenc
stage
heart
enlarg
echocardiographi
defin
lviddn
la
ao
venipunctur
blood
collect
storag
perform
previous
describ
healthi
dog
recruit
describ
provid
uniform
equilibrium
concentr
result
stage
b
c
best
reflect
clinic
practic
institut
dog
stage
b
prohibit
receiv
acei
wherea
dog
stage
c
requir
receiv
acei
plasma
equilibrium
concentr
differ
raa
ap
includ
angiotensin
angiotensin
angiotensin
iii
angiotensin
iv
angiotensin
angiotensin
quantifi
liquid
spectrometrymass
spectroscopi
perform
commerci
laboratori
attoqu
diagnost
vienna
austria
use
previous
valid
describ
test
sampl
human
shown
similar
qualit
outcom
compar
quantif
circul
equilibrium
ap
two
addit
calcul
perform
use
equilibrium
ap
concentr
first
calcul
surrog
measur
plasma
renin
activ
prasurr
calcul
sum
concentr
second
surrog
measur
ace
activ
acesurr
calcul
ratio
explor
effect
exogen
rel
concentr
select
raa
ap
plasma
sampl
stage
stage
c
dog
also
incub
recombin
human
r
system
minneapoli
minnesota
follow
measur
equilibrium
concentr
detail
regard
method
valid
well
lower
limit
quantif
measur
ap
present
support
inform
descript
statist
variou
patient
group
gener
normal
test
use
test
nonparametr
test
use
data
normal
distribut
data
lower
limit
quantif
particular
assay
enter
valu
equal
time
lower
limit
quantif
previous
presenc
extrem
outli
data
point
identifi
grubb
test
restrict
potenti
remov
data
point
data
differ
unpair
group
test
use
wilcoxon
rank
sum
unpair
test
differ
across
group
test
use
analysi
varianc
anova
post
hoc
pairwis
comparison
perform
use
dunn
test
correct
multipl
comparison
bonferroni
correct
respect
box
whisker
plot
construct
line
repres
median
valu
limit
box
repres
percentil
whisker
extend
percentil
correl
among
variou
patient
demograph
data
echocardiograph
variabl
assay
result
explor
use
pearson
correl
coeffici
spearman
rho
unadjust
p
valu
concentr
ap
administr
evalu
wilcoxon
sign
rank
test
data
shown
median
interquartil
rang
unless
otherwis
specifi
statist
procedur
perform
use
statist
softwar
prism
os
x
graphpad
softwar
inc
la
jolla
california
signific
defin
p
tissu
dog
obtain
includ
control
dog
euthan
noncardiac
diseas
dog
euthan
chf
relat
dmvd
control
dog
heart
murmur
histori
clinic
sign
heart
diseas
includ
follow
femal
spay
mix
breed
dog
pain
back
vomit
poor
appetit
male
neuter
west
highland
white
terrier
refractori
seizur
male
neuter
french
bulldog
upper
airway
obstruct
dog
heart
diseas
includ
follow
femal
spay
mix
breed
dog
sever
chf
receiv
furosemid
hydrochlorothiazid
enalapril
pimobendan
spironolacton
male
neuter
cocker
spaniel
sever
chf
receiv
furosemid
benazepril
hydrocodon
sildenafil
pimobendan
femal
spay
chihuahua
sever
chf
receiv
furosemid
enalapril
immunoreact
present
kidney
control
dmvd
dog
figur
immunolabel
especi
evid
diffus
apic
border
epitheli
cell
proxim
convolut
tubul
granular
cytoplasm
immunolabel
variabl
intens
also
note
proxim
convolut
tubul
segment
nephron
immunoreact
present
lv
myocardium
control
affect
dog
figur
stain
patchi
variabl
intens
sarcoplasm
immunolabel
cardiomyocyt
visual
review
slide
identifi
readili
appar
differ
locat
intens
stain
group
cohort
dog
recruit
activ
mumg
dog
male
healthi
miniatur
poodl
found
extrem
outlier
exclud
final
analysi
thu
analysi
set
consist
dog
includ
healthi
dog
dog
either
stage
c
chf
caus
dmvd
signal
treatment
time
sampl
shown
tabl
valid
data
assay
present
support
inform
median
plasma
activ
dog
chf
mumg
significantli
higher
healthi
dog
mumg
p
figur
result
consist
regardless
whether
outlier
valu
includ
analysi
signific
correl
found
activ
age
r
p
bodi
weight
spearman
r
p
healthi
cohort
kidney
lv
myocardi
tissu
obtain
dog
noncardiac
diseas
sever
dmvd
dog
tissu
previous
use
ihc
includ
dmvd
control
includ
cohort
dog
euthan
cardiac
diseas
receiv
acei
noncardiac
reason
death
dog
noncardiac
diseas
includ
pulmonari
airway
diseas
neurolog
diseas
neoplasia
dog
unspecifi
caus
back
pain
vomit
four
dog
male
noncardiac
dmvd
cohort
respect
p
mean
sd
age
year
dog
without
cardiac
diseas
dmvd
dog
respect
p
lv
activ
mumg
control
dog
year
old
splenic
mass
extrem
outlier
valu
exclud
lv
analysi
mean
sd
activ
kidney
mumg
lv
myocardium
mumg
noncardiac
group
significantli
differ
result
dmvd
group
kidney
mumg
lv
mumg
p
kidney
result
p
lv
result
figur
result
regardless
whether
outlier
valu
includ
analysi
activ
per
milligram
protein
kidney
tissu
approxim
time
higher
circul
lv
myocardi
activ
assay
circul
tissu
activ
perform
averag
day
rang
date
sampl
collect
cohort
dog
consist
healthi
dog
dog
stage
dmvd
dog
stage
dmvd
dog
stage
c
includ
dog
dmvd
dog
dcm
recruit
signal
treatment
time
sampl
present
tabl
differ
concentr
across
group
detect
number
ap
includ
tabl
gener
concentr
ap
highest
dog
stage
c
intermedi
stage
lowest
healthi
dog
figur
global
overview
expand
raa
identifi
larg
differ
overal
activ
rel
amount
ap
across
patient
group
figur
note
median
time
higher
stage
c
healthi
stage
dog
respect
median
stage
c
time
higher
healthi
stage
dog
respect
median
stage
c
time
higher
healthi
stage
dog
differ
across
group
found
number
ap
includ
signific
posit
modest
correl
lviddn
la
ao
affect
dog
see
support
inform
median
surrog
plasma
renin
activ
prasurr
significantli
differ
across
patient
group
figur
median
prasurr
stage
c
approxim
time
higher
healthi
dog
dog
stage
respect
tabl
median
acesurr
also
significantli
differ
across
patient
group
figur
median
acesurr
stage
c
time
lower
healthi
dog
dog
stage
tabl
addit
plasma
sampl
dog
stage
dog
stage
c
significantli
increas
pair
median
equilibrium
concentr
sever
ap
decreas
concentr
other
figur
support
inform
specif
concentr
decreas
stage
dog
pgml
pgml
p
pgml
pgml
p
dog
stage
c
concentr
stage
dog
decreas
pgml
pgml
p
pgml
pgml
p
dog
stage
c
concentr
increas
stage
dog
pgml
pgml
p
pgml
pgml
p
dog
stage
c
concentr
stage
dog
increas
pgml
pgml
p
pgml
pgml
p
dog
stage
c
concentr
stage
dog
increas
pgml
pgml
p
pgml
pgml
p
dog
stage
c
assay
raa
ap
equilibrium
analysi
raa
ap
equilibrium
analysi
incub
perform
averag
day
rang
day
rang
date
sampl
collect
respect
discoveri
relat
ap
figur
subject
intens
studi
human
heart
knowledg
studi
first
provid
expand
view
raa
dog
heart
diseas
result
identifi
immunolabel
activ
canin
lv
myocardium
previou
report
indic
similar
find
suggest
import
role
cardiac
function
strong
immunolabel
high
degre
activ
also
found
renal
tubular
epithelium
consist
previou
studi
result
indic
system
regul
differ
dog
heart
diseas
compar
healthi
dog
first
plasma
activ
significantli
increas
dog
chf
similar
previou
report
human
patient
heart
diseas
serum
activ
significantli
increas
secondari
ischem
nonischem
heart
diseas
independ
medic
comorbid
serum
activ
posit
correl
echocardiograph
heart
size
neg
correl
heart
function
independ
associ
import
clinic
event
includ
death
hospit
role
circul
solubl
oppos
fulli
understood
previous
mention
integr
protein
balanc
tissu
versu
circul
mediat
membran
metalloproteinas
cleav
portion
cell
membran
releas
surround
extracellular
result
ectosom
contain
well
immedi
surround
extracellular
environ
enter
circul
urin
process
describ
ectodomain
previou
indic
shed
frequent
shed
ace
also
highli
membran
bound
tumor
necrosi
factor
interleukin
disintegrin
metalloproteas
potent
stimuli
shed
mice
thu
increas
circul
might
repres
patholog
displac
normal
tissu
membran
locat
mediat
part
feedback
loop
variou
substanc
decreas
activ
neg
result
circul
remov
normal
locat
ideal
environ
hypothes
repres
wast
ineffect
studi
activ
circul
normal
protein
amount
approxim
less
activ
kidney
support
hypothesi
result
howev
also
indic
kidney
lv
activ
significantli
differ
dog
chf
compar
healthi
dog
suggest
shed
import
factor
total
extent
activ
loss
tissu
circul
would
tend
decreas
overal
compensatori
potenti
elucid
seemingli
complex
relationship
circul
tissu
need
second
import
find
studi
relationship
rel
concentr
variou
ap
within
expand
raa
provid
insight
pathophysiolog
diseas
begin
first
portion
raa
figur
result
indic
heart
diseas
dog
associ
increas
plasma
renin
activ
find
consist
previou
report
lead
higher
concentr
stage
downstream
activ
raa
gener
appear
mild
also
consist
previou
studi
neurohormon
activ
specif
data
indic
higher
concentr
stage
compar
healthi
dog
chang
fail
reach
statist
signific
yet
chf
develop
ie
stage
c
pra
greatli
increas
serv
potenti
substrat
gener
downstream
ap
figur
studi
dog
stage
c
receiv
acei
prevent
convers
larg
amount
thu
concentr
significantli
differ
stage
c
compar
patient
group
instead
result
indic
dog
chf
presum
cleav
proteas
aminopeptidas
amp
neutral
endopeptidas
significantli
higher
concentr
action
ap
particular
studi
varieti
speci
includ
human
dog
rat
includ
vasodilat
natriuresi
activ
nitric
oxid
antagon
protect
ischemia
reperfus
injuri
simul
natriuret
peptid
releas
improv
glycolysi
high
energi
phosphat
thu
report
acei
dog
chf
might
result
increas
concentr
salutari
action
well
inhibit
format
find
within
expand
raa
indic
exist
close
relat
biolog
distinct
group
ap
promot
chf
phenotyp
act
counterbal
work
shift
balanc
within
raa
back
toward
benefici
ap
result
also
provid
new
inform
less
ap
exact
biolog
action
certain
ap
incomplet
understood
predict
base
extens
studi
anim
model
previou
studi
indic
bind
therebi
elicit
effect
similar
within
central
nervou
system
final
effector
molecul
mediat
effect
releas
vasopressin
pituitari
contrast
despit
differ
singl
amino
acid
bind
masr
novel
receptor
elicit
effect
similar
includ
prevent
apoptosi
vasodilat
figur
studi
equilibrium
concentr
dog
heart
diseas
significantli
differ
healthi
dog
reason
find
dog
preclin
diseas
might
stem
rel
low
overal
activ
raa
wherea
dog
sever
diseas
chf
format
precursor
primarili
mediat
ace
would
block
presenc
acei
subsequ
low
amount
would
limit
downstream
format
figur
rel
littl
known
ap
expand
raa
previou
report
vasodilatori
antiprolif
wherea
anoth
report
vasoconstrict
like
convers
remain
ap
human
ang
induc
mild
ang
thought
central
act
bind
masr
caus
vasodilat
increas
natriuret
peptid
thu
result
raa
ap
equilibrium
analysi
dog
chf
receiv
acei
indic
increas
benefici
ap
includ
chang
benefici
ap
includ
increas
maladapt
ap
includ
chang
maladapt
ap
includ
data
offer
insight
pathophysiolog
diseas
suggest
novel
treatment
approach
discuss
third
import
find
studi
abil
shift
balanc
ap
within
raa
use
counter
regulatori
role
maladapt
effect
ace
make
relat
ap
attract
target
treatment
exogen
particularli
interest
light
fact
affin
cleav
benefici
greater
affin
ace
cleav
suggest
exogen
activ
would
capabl
convert
even
larg
amount
studi
incub
plasma
sampl
dog
stage
stage
c
heart
diseas
result
significantli
higher
equilibrium
concentr
benefici
ap
includ
simultan
decreas
concentr
maladapt
ap
includ
previou
involv
human
serum
healthi
volunt
report
similar
increas
benefici
ap
suppress
maladapt
ap
led
earli
human
pulmonari
hypertens
collect
data
provid
conceptu
support
therapi
target
system
data
also
suggest
methodolog
employ
studi
name
equilibrium
analysi
ap
use
preclin
analyt
tool
studi
number
limit
larger
studi
need
confirm
find
rel
small
number
anim
studi
plasma
activ
quantifi
dog
chf
secondari
advanc
dmvd
import
differ
might
exist
dog
earli
dmvd
anim
caus
chf
potenti
correl
among
circul
activ
durat
chf
administr
medic
clinic
outcom
requir
longitudin
studi
clinic
implic
circul
appear
complex
exampl
although
previou
observ
determin
increas
activ
associ
poor
outcom
studi
involv
patient
intens
treatment
acut
increas
activ
baselin
associ
improv
surviv
number
sampl
obtain
kidney
lv
myocardi
activ
small
difficulti
procur
sampl
futur
studi
larger
popul
might
identifi
import
differ
evalu
expand
raa
perform
use
equilibrium
analysi
report
concentr
higher
actual
circul
concentr
valu
highli
preserv
abil
ascertain
rel
differ
among
ap
expand
model
raa
remain
simpl
represent
highli
complex
pathophysiolog
network
mani
addit
identifi
unidentifi
compon
relationship
regardless
propos
raa
model
offer
new
insight
proof
concept
novel
treatment
strategi
dog
receiv
varieti
cardiac
medic
includ
diuret
agent
acei
spironolacton
might
influenc
result
dog
raa
ap
equilibrium
analysi
includ
dog
dmvd
dcm
import
differ
magnitud
raa
ap
concentr
might
exist
studi
specif
examin
effect
variou
treatment
raa
interest
exampl
previou
studi
ame
mk
potter
bk
hess
effect
loop
diuret
novel
compon
system
healthi
dog
abstract
proceed
acvim
forum
seattl
wa
dog
compar
rel
extent
raa
activ
administr
furosemid
compar
torsemid
analyz
equilibrium
concentr
wherea
report
increas
mediat
combin
treatment
angiotensin
receptor
blocker
serum
sampl
human
final
healthi
dog
weigh
kg
requir
undergo
echocardiograph
studi
incid
asymptomat
dcm
popul
dog
like
low
summari
result
provid
novel
inform
presenc
distribut
activ
equilibrium
concentr
compon
system
expand
view
raa
dog
heart
diseas
activ
tradit
compon
raa
significantli
differ
affect
dog
potenti
new
target
treatment
identifi
studi
provid
proof
concept
could
modifi
raa
manner
would
increas
newli
describ
benefici
ap
suppress
maladapt
ap
consider
expand
raa
includ
relat
ap
open
new
opportun
understand
treat
heart
diseas
dog
author
declar
conflict
interest
author
declar
use
antimicrobi
univers
pennsylvania
iacuc
approv
author
declar
human
ethic
approv
need
studi
